Summary

Eligibility
for people ages 30 years and up (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UCLA
Dates
study started
completion around
Principal Investigator
by David Liebeskind, MD (ucla)

Description

Summary

An observational study to determine if individuals with increased platelet FcyRIIa will have a higher risk of ischemic events.

Official Title

Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosi

Details

Keywords

Stroke, TIA, Ischemic Stroke, Ischemic, Ischemia, Medical Imaging

Eligibility

Location

  • Ronald Reagan UCLA Medical Center accepting new patients
    Los Angeles California 90095 United States

Lead Scientist at University of California Health

  • David Liebeskind, MD (ucla)
    Professor of Clinical, Neurology, Medicine. Authored (or co-authored) 756 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT05518305
Study Type
Observational
Participants
Expecting 250 study participants
Last Updated